Instalab
logoInstalab

HOMA-IR

Blood Test
Estimate whether insulin resistance is building while fasting glucose still looks normal.
4.9 (2,564 reviews)
Tested by Quest, Access Medical or Boston Heart
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers · 8-hour fast required
Get results
Explained with clear next steps, no medical jargon

Should you take a HOMA-IR test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
Your glucose and HbA1c look normal, but you want an early read on insulin strain.
Told Your Blood Sugar Is Borderline
You have prediabetes or borderline glucose and want to see whether insulin is carrying the load.
Living With PCOS
You have PCOS and want a fasting insulin-resistance signal to read with symptoms and other labs.
Gaining Weight Around the Middle
You carry more weight at the waist or have family history of diabetes and want a baseline.

About HOMA-IR

Insulin resistance can build quietly. Your pancreas makes more insulin to keep blood sugar normal, and for years it may succeed. A routine fasting glucose test can look fine while the system is under strain.

HOMA-IR estimates how hard that system is working. It is a practical early signal for the biology that can lead to type 2 diabetes, heart disease, and fatty liver, but it is not a diagnosis by itself. You get it from a fasting blood draw.

What the Number Actually Is

HOMA-IR is a calculation, not a substance in your blood. The full name is Homeostatic Model Assessment of Insulin Resistance. A lab measures two things after an overnight fast: your blood glucose and your insulin. Insulin resistance means your cells respond weakly to insulin, so the pancreas has to release more of it to get the same job done. When both fasting glucose and fasting insulin run high, the score climbs.

The score mainly reflects insulin resistance in the fasting state, where the liver matters a lot. It is a stand-in for a research reference method that holds blood sugar steady while measuring insulin action. That procedure is slow and expensive, so it is rarely used outside studies. HOMA-IR trades some precision for the fact that you can actually get it done.

There Is No Single Normal Number

There is no universal cutoff. What counts as concerning depends on age, sex, body weight, ancestry, and the specific insulin assay a lab uses. Research cutoffs vary widely across populations, even when investigators are trying to describe roughly the same biology.

So treat HOMA-IR as a metabolic signal, not a pass-fail line. The most useful comparison is your own number over time, read alongside the rest of your metabolic picture. A value that looks unremarkable in isolation can still matter if it is rising, and a modestly high one can be less alarming if everything else is clean. The direction and the context carry the meaning, not the single digit.

Type 2 Diabetes

A higher HOMA-IR can show metabolic strain before fasting glucose or HbA1c cross diabetes lines. In a pooled analysis of adults with metabolic risk factors, those with high HOMA-IR had nearly twice the risk of developing type 2 diabetes. In a long Korean cohort of adults without diabetes, high HOMA-IR predicted new-onset diabetes even after accounting for baseline HbA1c.

This is the practical value of the test. Fasting glucose and HbA1c tell you where your blood sugar is now. HOMA-IR tells you how much strain the system is already under, which is the part that often moves first.

Heart Disease and Stroke

Insulin resistance is tied to cardiovascular risk before blood sugar crosses a diabetes line. A meta-analysis pooling 65 studies and 516,325 people found that high HOMA-IR carried about 64% higher risk of coronary heart disease, and it tracked heart risk better than fasting glucose or fasting insulin measured alone.

The trajectory matters more than any one reading. In adults followed over time, those whose HOMA-IR climbed had roughly 60% higher risk of a first cardiovascular event and more than double the risk of dying from one. In younger adults tracked for three decades, a persistently high HOMA-IR path meant more than triple the stroke risk. The risk is not spread evenly, though. In a very large nationwide study, the link between HOMA-IR and heart disease was strongest in people who already had prediabetes or diabetes, and weakest in those with normal glucose.

Kidney Function

Rising insulin resistance also tracks with declining kidney function. In more than five thousand adults, those whose HOMA-IR increased over time had a higher risk of adverse kidney outcomes after accounting for other factors, and the link held whether or not they had diabetes. It is one more reason the trend is worth watching rather than a single snapshot.

PCOS, Pregnancy, and Fertility

Insulin resistance is common in polycystic ovary syndrome, though not everyone with PCOS has it. It can show up even without extra weight. In one observational study of women with PCOS, HOMA-IR flagged more insulin resistance than fasting insulin alone.

The signal extends into pregnancy, but the evidence is more situation-specific. Higher HOMA-IR before IVF or ICSI embryo transfer was linked to nearly four times the odds of late miscarriage in women without PCOS or lipid problems. In gestational diabetes, higher insulin resistance was associated with high blood pressure in pregnancy and larger babies, though it did not predict every complication. In early pregnancy it is only a moderate predictor of gestational diabetes, and useful thresholds shift with body weight.

Why One Reading Can Fool You

HOMA-IR is noisier than most people assume, and a single value can mislead. In a study that measured the same healthy people ten weeks in a row, HOMA-IR varied by about 27% within a person, mostly from natural week-to-week variation in insulin. That alone is a strong argument against reading too much into one draw.

  • Not fasting properly: the calculation only holds if you have truly fasted overnight. A recent meal can produce high values that say more about the meal than your baseline metabolism.
  • Different labs, different insulin assays: insulin methods vary in how they are calibrated. Numbers from two labs are not directly comparable unless you know the same insulin method was used.
  • It can miss hidden resistance: HOMA-IR captures fasting, liver-weighted insulin resistance. It can look normal while muscle-based insulin resistance only shows up after a sugar load.
  • Injected insulin or changing diabetes medication: the model assumes fasting insulin mostly reflects what your pancreas released. Injected insulin and recent medication changes can make the score hard to interpret.
  • Certain conditions distort it: in some hormone disorders, such as acromegaly, HOMA-IR may fail to match the rest of the metabolic picture. It is not reliable everywhere.

Tracking Your Trend

Because a single HOMA-IR can bounce around by roughly a quarter, the trend carries more weight than one reading. One result gives you a rough placement. A series tells you which way your metabolism is heading and whether a diet, weight, or medication change is taking hold.

Reading It in Context

HOMA-IR works best when it agrees with the rest of the pattern. High triglycerides, low HDL, and weight carried around the middle alongside a rising HOMA-IR all point the same direction and make the insulin resistance picture more consistent.

If fasting glucose and HbA1c still look normal but suspicion is strong, a glucose tolerance test that also measures insulin can reveal resistance that a fasting number misses. The triglyceride-to-glucose index is a cheaper companion signal that sometimes tracks these outcomes as well or better. A clearly rising HOMA-IR clustered with other metabolic findings is worth acting on. An isolated, mildly elevated value with an otherwise clean profile is mainly a reason to confirm the trend.

What Moves This Biomarker

Evidence-backed interventions that affect your HOMA-IR level

↓ Decrease
Take tirzepatide, a weekly GIP and GLP-1 medication
Tirzepatide improves insulin sensitivity in people with type 2 diabetes. In a randomized trial of 316 adults, tirzepatide improved HOMA2-IR, a related fasting insulin-glucose model, and improved insulin-making cell function more than dulaglutide.
MedicationStrong Evidence
↓ Decrease
Switch to a low-fat plant-based diet
Eating this way can lower HOMA-IR over months. In a 16-week randomized trial of 75 overweight adults without diabetes, a low-fat plant-based diet lowered HOMA-IR compared with making no diet change.
DietModerate Evidence

Frequently Asked Questions

References

22 studies
  1. Horáková D, ŠTěpánek L, Janout V, Janoutová J, Pastucha D, Kollárová H, Petráková a, ŠTěpánek L, Husár R, Martiník KMedicina2019
  2. Gayoso-diz P, Otero-gonzález a, Rodríguez-álvarez M, Gudé F, García F, De Francisco AD, Quintela aBMC Endocrine Disorders2013
  3. Diniz M, Beleigoli a, Schmidt M, Duncan B, Ribeiro a, Vidigal PG, Benseñor I, Lotufo P, Santos I, Griep R, Barreto SCadernos De Saude Publica2020
  4. Tahapary D, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka a, Tarigan TJ, Harbuwono D, Purnamasari D, Soewondo PDiabetes & Metabolic Syndrome2022